Jammie Law is a New Brunswick, New Jersey based female rheumatologist who is specialized in Rheumatology. Active license number of Jammie Law for Rheumatology is 25MA11911000 in New Jersey. Jammie Law treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Jammie Law speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
125 Paterson St # 5200a, New Brunswick, New Jersey, 08901-1962
Phone:
732-235-6525
Fax:
732-235-6526
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1922503150
NPI Enumeration Date:
29 Mar, 2018
NPI Last Update On:
27 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jammie Law are as mentioned below.
License Number
Specialization
State
Status
25MA11911000
Rheumatologist
New Jersey
Primary
310250
Rheumatology
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
125 Paterson St # 5200a, New Brunswick, New Jersey
Zip:
08901-1962
Phone Number:
732-235-6525
Fax Number:
732-235-6526
Patients can reach Jammie Law at 125 Paterson St # 5200a, New Brunswick, New Jersey or can call to book an appointment on 732-235-6525. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.